3RD ANNUAL INHALATION AND RESPIRATORY DRUG DELIVERY CONFERENCE

Thanks to the developments of the modern medicine, inhalers have become the most effective way of delivering respiratory drugs. 3rd Annual Inhalation and Respiratory Drug Delivery Conference will give you a unique opportunity to discuss the high efficiency delivery systems, the new challenges and approaches of the inhaler models on the market.The agenda also features the global regulatory CMC requirements, key studies on the latest trends in inhalation devices and personalized treatments with large and small molecules for different respiratory diseases. Presentations will also be focused on the topics, such as: cell therapy, inhaled vaccines and the future potential for high-dose applicants and available liquid inhalation devices. The event is modeled for the senior manager representatives, experts and main decision makers who are interested to be acquainted with the latest approaches and inventions of the respiratory drug products delivery field.

WHO SHOULD ATTEND:

CEOs, VPs, Drug developers, Academics and Researchers, CROs, Scientists and Medical Doctors of:

 E-Health

 Inhalation

 Outsourcing

 Respiratory R&D

 Connective Health

 Medical Marketing

 Inhalation Devices

 Scientific Research

 Pulmonary Disease

 Device Engineering

 Respiratory Medicine

 Process Development

 Business Development

 Generics & Respiratory

 Inhaled Dosage Forms

 Respiratory Regulations

 Respiratory Regulations

 Inhalation Drug Delivery

 Particle Characterisation

 Drug Delivery Innovation

 New Delivery Technologies

 Respiratory Pharmacology

 Medical Devices & Injectors

 Inhaled Formulation Science

 Inhalation Device Development

 Inhalation Product Development

 Inhalation Process Development

 Respiratory Drug Development

 Metered Dose Inhaler Development

 Inhalation Drug Delivery Technologies

 Device Development and Engineering

KEY POINTS:

• Analytical approaches and specifications

• Overview of the available liquid inhalation devices

• Challenges requirements and opportunities of the inhaler models on the market

• Advantages of the large and small molecules for inhaled therapy

• The future potential of the soft mist inhaler for high dose applicants

• The new approaches of therapeutic fields for lung cancer

• Overview of a personalized treatment in Asthma

• Local technical development of the inhalation product and global regulatory CMC requirements

BENEFITS FOR ATTENDEES

 Hear from an unrivalled faculty of speakers

 Discover what is new in nebulised therapy

 Explore new concepts in inhaled corticosteroid therapeutic equivalence

 Gain new analytical insights into dry powder formulations for inhalation

 Understand the challenges with triple combination inhalers

 Consider the environment with inhaler devices

 Discuss success criteria in technology transfer

 Review new inhalation technologies

 Hear about innovation in productiontechnologies

 Understand the regulatory requirements for respiratory products

 Gain an insight into the regulatory position post Brexit

 Learn about human factors and its relevance in product development

 Explore opportunities with smart and digital inhalers

TO DISCUSS THE ATTENDEE OPPORTUNITIES OR REGISTER FOR THE EVENT PLEASE CONTACT:

For Speaking Opportunities:
Kara Koz
Conference Producer
Tel.: +420 228 227 163
E-mail: kara.koz@bcf-events.com
For Attendee Opportunities | Sponsors | Exhibition
Valerie Neumann
Marketing Manager
Tel.: +420 228 227 162
E-mail: valerie.neumann@bcfgroup.eu